Banská Štiavnica (SK) Cancer Clinical Trials

Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

~86 mi. (Tatabánya, Hungary, +206 more cities)

Szent Borbála Kórház

Non-Squamous Non-Small Cell Lung Carcinoma

nivolumab, +1 more drug

immunotherapy, +1 more type

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~89 mi. (Budapest, Hungary, +226 more cities)

Országos Onkológiai Intézet-Urogenital Tumors Department and Clinical Pharmacology ( Site 1325)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

~89 mi. (Budapest, Hungary, +69 more cities)

National Institute of Oncology Hungary

Cervical Adenocarcinoma, +2 more conditions

tisotumab vedotin

chemotherapy, +1 more type

Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma

~89 mi. (Budapest, Hungary, +42 more cities)

Országos Onkológiai Intézet

Esophageal Squamous Cell Carcinoma

cisplatin/fluorouracil regimen, +2 more drugs

chemotherapy, +1 more type

Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients

~89 mi. (Budapest, Hungary, +31 more cities)

Novartis Investigative Site

Myelofibrosis

crizanlizumab, +5 more drugs

immunotherapy, +2 more types

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003)

~95 mi. (Törökbálint, Hungary, +93 more cities)

Torokbalint Tudogyogyintezet-Onkopulmonologiai Jarobeteg Centrum ( Site 1208)

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

vibostolimab/pembrolizumab MK-7684A

immunotherapy

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

~95 mi. (Törökbálint, Hungary, +122 more cities)

Tudogyogyintezet Torokbalint ( Site 1304)

Small Cell Lung Carcinoma

etoposide, +5 more drugs

chemotherapy, +3 more types

Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)

~95 mi. (Törökbálint, Hungary, +145 more cities)

Tudogyogyintezet Torokbalint ( Site 2302)

Non-Small Cell Lung Carcinoma

pembrolizumab, +1 more drug

immunotherapy, +2 more types

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

~95 mi. (Törökbálint, Hungary, +28 more cities)

Torokbalint Tudogyogyintezet-Onkopulmonologiai Jarobeteg Centrum ( Site 2801)

Small Cell Lung Carcinoma

carboplatin, +6 more drugs

chemotherapy, +2 more types